Announcements Trials
Browse Landscape

Phase

Phase NA 7Phase 3 5Phase 2 5Phase 1/2 3Phase 1 3Phase EARLY_PHASE1 2

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2

Conditions

Glioblastoma 17Glioma 15Breast Neoplasms 14Prostatic Neoplasms 13Neoplasms 13Brain Neoplasms 11Pancreatic Neoplasms 10Colorectal Neoplasms 10Neoplasm Metastasis 9Multiple Myeloma 8Lymphoma, B-Cell 8Recurrence 7Melanoma 7Lymphoma 6Carcinoma, Renal Cell 6Triple Negative Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Head and Neck Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Skin Neoplasms 4Lung Neoplasms 4Carcinoma, Hepatocellular 4Advanced Solid Tumors 4Solid Tumor 3Pituitary Neoplasms 3Neoplasms, Plasma Cell 3Myelodysplastic Syndromes 3Lymphoma, Follicular 3Leukemia, Myeloid, Acute 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Immunoglobulin Light-chain Amyloidosis × 90 days × Clear all
NCT07626476 2026-06-04

Autologous BCMA-targeted CAR-T Cell Injection for Relapsed/Refractory Light Chain Amyloidosis

Beijing Boren Hospital

Phase EARLY_PHASE1 Recruiting
30 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Recurrence

NCT07615270 2026-05-29

A Pilot Study of Anselamimab in Patients With AL Amyloidoma and Measurable Tissue Involvement

Stanford University

Phase EARLY_PHASE1 Not yet recruiting
5 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡